“…EGR1 regulates the expression of genes encoding inflammation-related proteins, such as IL-33-induced TSLP [ 45 ], IL-17-induced psoriasin [ 61 ], and IL-13-induced kallikrein-related peptidase 7 (KLK7) in keratinocytes [ 62 ]. Recently, we demonstrated that immune cell infiltration in AD-like skin lesions was substantially attenuated in Egr1 -knockout mice, and the TNFα-induced expression of cytokines, including TSLP, IL-1β, IL-6, CXCL1, CCL2, and CCL5, was inhibited in response to EGR1 knockdown [ 42 ]. Furthermore, the AB1711 compound, a small-molecule inhibitor targeting the EGR1 zinc-finger DNA-binding domains, was shown to abrogate the expression of EGR1-regulated inflammatory cytokines in keratinocytes and improve both skin inflammation and itching in DNCB-challenged NC/Nga mice [ 42 ].…”